Fig. 6.
Fig. 6. Production of FBG by lung epithelial cells stimulated with pro-inflammatory mediators. Immunoprecipitation of secreted (media) and intracellular (cells) FBG was performed using purified rabbit antihuman FBG IgG coupled to Protein A-Sepharose. (A) A fluorograph of immunoprecipitated proteins electrophoresed on a 5% to 15% polyacrylamide gel after reduction and denaturation. Untreated HepG2 cells served as the positive control cell line for FBG biosynthesis. In lane 1, untreated HepG2 cells; lane 2, untreated A549 cells; lane 3, DEX-treated A549 cells; lane 4, IL-6–treated A549 cells; lane 5, DEX + IL-6–treated A549 cells. The position of migration of the FBG Aα, Bβ, and γ chain polypeptides is denoted. Fibronectin (FN) bound nonspecifically to anti-FBG IgG-Protein A-Sepharose. (B) A 2% agarose gel electrophoresis of nonreduced FBG immunoprecipitated from media of metabolically labeled A549 cells treated as described for (A), lanes 2-5; lane 1, nonreduced FBG immunoprecipitated from untreated, metabolically labeled HepG2 cell conditioned media. Molecular weight markers are denoted in the left margin.

Production of FBG by lung epithelial cells stimulated with pro-inflammatory mediators. Immunoprecipitation of secreted (media) and intracellular (cells) FBG was performed using purified rabbit antihuman FBG IgG coupled to Protein A-Sepharose. (A) A fluorograph of immunoprecipitated proteins electrophoresed on a 5% to 15% polyacrylamide gel after reduction and denaturation. Untreated HepG2 cells served as the positive control cell line for FBG biosynthesis. In lane 1, untreated HepG2 cells; lane 2, untreated A549 cells; lane 3, DEX-treated A549 cells; lane 4, IL-6–treated A549 cells; lane 5, DEX + IL-6–treated A549 cells. The position of migration of the FBG Aα, Bβ, and γ chain polypeptides is denoted. Fibronectin (FN) bound nonspecifically to anti-FBG IgG-Protein A-Sepharose. (B) A 2% agarose gel electrophoresis of nonreduced FBG immunoprecipitated from media of metabolically labeled A549 cells treated as described for (A), lanes 2-5; lane 1, nonreduced FBG immunoprecipitated from untreated, metabolically labeled HepG2 cell conditioned media. Molecular weight markers are denoted in the left margin.

Close Modal

or Create an Account

Close Modal
Close Modal